Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
NYSE:PRGO
Price:
27.53 USD
-0.15%
Market Closed
Updated:
Jun 3, 2024
Perrigo Company PLC
Total Equity
|
Perrigo Company PLC
Total Equity Peer Comparison
Comparables:
JAZZ
AVDL
G
GHRS
COPN
OVB
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Total Equity
$4.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Total Equity
$3.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Total Equity
$78.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Total Equity
$219m
|
CAGR 3-Years
237%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Total Equity
€456.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Total Equity
€8.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-13%
|
See Also
What is Perrigo Company PLC's Total Equity?
Total Equity
4.7B
USD
4.7B
USD
Based on the financial report for Mar 30, 2024, Perrigo Company PLC's Total Equity amounts to 4.7B USD.
What is Perrigo Company PLC's Total Equity growth rate?
Total Equity CAGR 10Y
-6%
-6%
Over the last year, the Total Equity growth was -3%. The average annual Total Equity growth rates for Perrigo Company PLC have been -6% over the past three years , -4% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
